Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

KVA

K V Pharma CL A (KVA)

K V Pharma CL A
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:KVA
DateTimeSourceHeadlineSymbolCompany
06/18/20128:04AMDow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS to WATCHNYSE:KVAK V Pharma CL A
06/18/20126:08AMDow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS to WATCHNYSE:KVAK V Pharma CL A
11/16/20117:15PMBusiness WireGlancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
11/02/20118:40PMBusiness WireLaw Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
10/31/20118:30PMBusiness WireGlancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
10/28/20113:30PMBusiness WireFaruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
10/24/201112:52PMBusiness WireThe Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
10/20/20117:47PMBusiness WireLaw Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
10/13/20118:02AMBusiness WireZeldes & Haeggquist, LLP Announces Investigation of K-V PharmaceuticalNYSE:KVAK V Pharma CL A
06/13/20117:00AMPR Newswire (US)K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference CallNYSE:KVAK V Pharma CL A
04/01/20112:08PMDow Jones NewsUPDATE: K-V Pharma Slashes Price Of Preterm Labor Drug Amid OutcryNYSE:KVAK V Pharma CL A
04/01/20119:28AMDow Jones NewsK-V Pharma Slashes Prices Of Preterm Labor Drug After FDA MoveNYSE:KVAK V Pharma CL A
03/31/20114:28PMDow Jones NewsReligious Groups Urge Drug Makers To Ease Up On Price HikesNYSE:KVAK V Pharma CL A
03/30/20112:58PMDow Jones NewsUPDATE: K-V Pharma Shares Drop On FDA Statement On Preterm Birth DrugNYSE:KVAK V Pharma CL A
03/30/201111:38AMDow Jones NewsK-V Pharma Shares Drop On FDA Statement On Preterm Birth DrugNYSE:KVAK V Pharma CL A
03/01/20117:49AMPR Newswire (US)K-V Pharmaceutical Company Announces $200 Million Private Debt OfferingNYSE:KVAK V Pharma CL A
02/14/20119:36AMPR Newswire (US)KV Pharmaceutical Company Announces Delay In Conference Call and Provides Overview Of Conference Call CommentsNYSE:KVAK V Pharma CL A
02/14/20119:34AMPR Newswire (US)K-V Pharmaceutical Company Announces Reliance on the Financial Distress Exception to NYSE's Shareholder Approval Policy to IssueNYSE:KVAK V Pharma CL A
02/14/20118:48AMPR Newswire (US)K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common StockNYSE:KVAK V Pharma CL A
02/04/20117:40AMPR Newswire (US)K-V Pharmaceutical Company to Host Investor Conference Call on February 14, 2011NYSE:KVAK V Pharma CL A
01/12/20118:03AMPR Newswire (US)K-V Pharmaceutical Company Updates Status of New Drug Application for Gestivaâ„¢NYSE:KVAK V Pharma CL A
09/14/20109:29AMDow Jones NewsK-V Pharmaceutical Enters Loan Agreement In Wake Of FDA ApprovalNYSE:KVAK V Pharma CL A
09/10/20108:53AMDow Jones NewsK-V Pharma Soars On FDA Approval To Return Product To MarketNYSE:KVAK V Pharma CL A
02/25/201012:53PMPR Newswire (US)KV Pharmaceutical Reaches Agreement with U.S. Department of JusticeNYSE:KVAN^CURN
01/28/20104:04PMBusiness WireRobbins Umeda LLP Announces Investigation of KV Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
01/20/20102:41PMDow Jones NewsUPDATE: Watson Pharma Benefits From Toprol Market PresenceNYSE:KVAK V Pharma CL A
01/20/20101:11PMDow Jones NewsWatson Pharma Continues To Benefit From Toprol Market PresenceNYSE:KVAK V Pharma CL A
01/11/20108:18AMPR Newswire (US)KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM)NYSE:KVA
01/07/20103:10PMPR Newswire (US)KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of DirectorNYSE:KVA
12/22/20094:34PMPR Newswire (US)KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010NYSE:KVA
 Showing the most relevant articles for your search:NYSE:KVA